Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Erectile Dysfunction 4Prostatic Neoplasms 3Urinary Bladder Neoplasms 1Pre-Eclampsia 1Lymphoma, Follicular 1

Interventions

Cyclophosphamide 17Rituximab 12Prednisone 7Peripheral Blood Stem Cell Transplantation 7Filgrastim 7sargramostim 6Vincristine 6fludarabine phosphate 5Radiotherapy 5Doxorubicin 5Cytarabine 5Cisplatin 5ibritumomab tiuxetan 4Methylprednisolone 4Melphalan 4Etoposide 4Dexamethasone 4Cyclosporine 4epratuzumab 3Sensitivity and Specificity 3Polymerase Chain Reaction 3Mycophenolic Acid 3Indium 3Chlorambucil 3Busulfan 3Bendamustine Hydrochloride 3Antilymphocyte Serum 3Antigens, CD19 3obinutuzumab 2fludarabine 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Lymphoma, Follicular × Sildenafil Citrate × Clear all
NCT03262961 2017-08-28

Use of Sildenafil Citrate in Management of Mild Pre-eclampsia

Assiut University

Phase 2/3 Unknown
80 enrolled
Lymphoid

Lymphoma, Follicular, Pre-Eclampsia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡